Original Research
Published on 05 Oct 2022
Cross clinical-experimental-computational qualification of in silico drug trials on human cardiac purkinje cells for proarrhythmia risk prediction
in In Vitro Toxicology
- 9,205 views
- 13 citations
Original Research
Published on 05 Oct 2022
in In Vitro Toxicology
Original Research
Published on 23 Sep 2022
in In Vitro Toxicology
Perspective
Published on 09 Sep 2022
in In Vitro Toxicology
Review
Published on 01 Sep 2022
in In Vitro Toxicology
Original Research
Published on 22 Aug 2022
in In Vitro Toxicology
Original Research
Published on 05 Aug 2022
in In Vitro Toxicology
Original Research
Published on 18 Jul 2022
in In Vitro Toxicology
Original Research
Published on 17 Jun 2022
in In Vitro Toxicology
Original Research
Published on 15 Jun 2022
in In Vitro Toxicology
Original Research
Published on 06 Jun 2022
in In Vitro Toxicology
Original Research
Published on 02 Jun 2022
in In Vitro Toxicology
Original Research
Published on 02 May 2022
in In Vitro Toxicology
Original Research
Published on 02 May 2022
in In Vitro Toxicology
Review
Published on 29 Apr 2022
in In Vitro Toxicology
Original Research
Published on 28 Apr 2022
in In Vitro Toxicology
Original Research
Published on 19 Apr 2022
in In Vitro Toxicology
Perspective
Published on 30 Mar 2022
in In Vitro Toxicology
Original Research
Published on 24 Mar 2022
in In Vitro Toxicology
Original Research
Published on 07 Mar 2022
in In Vitro Toxicology
Original Research
Published on 07 Mar 2022
in In Vitro Toxicology
Original Research
Published on 07 Mar 2022
in In Vitro Toxicology
Brief Research Report
Published on 28 Feb 2022
in In Vitro Toxicology
Original Research
Published on 16 Feb 2022
in In Vitro Toxicology
Methods
Published on 03 Feb 2022
in In Vitro Toxicology